MedTrace Logo

Multimodal Physiotherapy for Balance and Vertigo in BPPV Patients

NCT07576088 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-05-08

No results posted yet for this study

Summary

This study aims to evaluate the effects of a multimodal physiotherapy approach on balance, vertigo, fear of falling, and quality of life in patients with benign paroxysmal positional vertigo (BPPV). BPPV is a common vestibular disorder that causes dizziness and balance problems, leading to an increased risk of falls and reduced quality of life. In this randomized controlled trial, participants will be assigned to two groups: one receiving a multimodal physiotherapy program including patient education, Epley maneuver, and balance training, and the other receiving standard Epley maneuver treatment. The intervention will be conducted over four weeks. Outcomes will be assessed using standardized tools for balance, vertigo, fear of falling, and quality of life. The study aims to determine whether a combined physiotherapy approach provides better outcomes than standard treatment alone.

Conditions

  • Benign Paroxysmal Positional Vertigo
  • Vertigo
  • Balance Disorder

Interventions

BEHAVIORAL

Multimodal Physiotherapy

A combined rehabilitation approach including vestibular rehabilitation, patient education, and balance training aimed at improving balance, reducing vertigo, decreasing fear of falling, and enhancing quality of life.

PROCEDURE

Epley Maneuver

A repositioning technique involving sequential head and body movements to relocate displaced otoconia within the semicircular canals to relieve symptoms of benign paroxysmal positional vertigo.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • wajeeha zia, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-05
Primary Completion
2026-07-06
Completion
2026-08-06

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07576088 on ClinicalTrials.gov